» Articles » PMID: 25963989

Tertiary Lymphoid Structures in Rheumatoid Arthritis: NF-κB-Inducing Kinase-Positive Endothelial Cells As Central Players

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2015 May 13
PMID 25963989
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Tertiary lymphoid structures (TLSs) in chronic inflammation, including rheumatoid arthritis (RA) synovial tissue (ST), often contain high endothelial venules and follicular dendritic cells (FDCs). Endothelial cell (EC)-specific lymphotoxin β (LTβ) receptor signaling is critical for the formation of lymph nodes and high endothelial venules. FDCs arise from perivascular platelet-derived growth factor receptor β(+) precursor cells (preFDCs) that require specific group 3 innate lymphoid cells (ILC3s) and LTβ for their expansion. Previously, we showed that RA ST contains ECs that express NF-κB-inducing kinase (NIK), which is pivotal in LTβ-induced noncanonical NF-κB signaling. We studied the relation between NIK(+) ECs, (pre)FDCs, and ILC3s with respect to TLSs in RA ST. TLS(+) tissues exhibited a significantly increased expression of genes involved in noncanonical NF-κB signaling, including NIK, and immunohistochemical analysis revealed that NIK was almost exclusively expressed by ECs. ILC3s were present in human RA ST in very low numbers, but not differentially in TLS(+) tissues. In contrast, TLS(+) tissues contained significantly more NIK(+) ECs and perivascular platelet-derived growth factor receptor β(+) preFDCs, which correlated significantly with the quantity of FDCs. We established a strong link between NIK(+) ECs, (pre)FDCs, and the presence of TLSs, indicating that NIK(+) ECs may not only be important orchestrators of lymph node development but also contribute to the formation of TLSs in chronic inflammation.

Citing Articles

Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances.

Zhao L, Jin S, Wang S, Zhang Z, Wang X, Chen Z Signal Transduct Target Ther. 2024; 9(1):225.

PMID: 39198425 PMC: 11358547. DOI: 10.1038/s41392-024-01947-5.


NF-κB in biology and targeted therapy: new insights and translational implications.

Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M Signal Transduct Target Ther. 2024; 9(1):53.

PMID: 38433280 PMC: 10910037. DOI: 10.1038/s41392-024-01757-9.


Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy.

Zou X, Guan C, Gao J, Shi W, Cui Y, Zhong X Front Immunol. 2023; 14:1222719.

PMID: 37529035 PMC: 10388371. DOI: 10.3389/fimmu.2023.1222719.


Lymphatic function and anatomy in early stages of lipedema.

Rasmussen J, Aldrich M, Fife C, Herbst K, Sevick-Muraca E Obesity (Silver Spring). 2022; 30(7):1391-1400.

PMID: 35707862 PMC: 9542082. DOI: 10.1002/oby.23458.


Lymph node formation and B cell homeostasis require IKK-α in distinct endothelial cell-derived compartments.

McCorkell K, Jayachandran N, Cully M, Freund-Brown J, Weinkopff T, Monslow J Proc Natl Acad Sci U S A. 2021; 118(48).

PMID: 34810256 PMC: 8640927. DOI: 10.1073/pnas.2100195118.